Status | Study |
Active, not recruiting |
Study Name: An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy Condition: Highly Drug-resistant Focal Epilepsy Date: 2015-12-04 Interventions: Drug: UCB0942 Active Subst |
Completed |
Study Name: National Network for the Study of Predictors and Prevention of Sudden Unexpected Death in Drug-resistant Partial Epilepsies Condition: Drug-resistant Partial Epilepsy Date: 2015-09-04 Interventions: Other: video-EEG Registration of seizures during video-EEG |
Active, not recruiting |
Study Name: A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy Condition: Highly Drug-resistant Focal Epilepsy Date: 2015-06-29 Interventions: Drug: UCB0942 Active substance |
Completed |
Study Name: Treatment of Difficult to Control Focal Epilepsy With Repetitive Transcranial Magnetic Stimulation (rTMS) Condition: Epilepsies, Partial Date: 2012-12-04 Interventions: Device: figure-of-eight active rTMS coil |
Withdrawn |
Study Name: Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects Condition: Epilepsy, Partial Date: 2012-09-13 Interventions: Drug: Retigabine Retigabine |
Recruiting |
Study Name: Brain P-gp and Inflammation in People With Epilepsy Condition: Epilepsies, Partial Date: 2012-08-08 |
Terminated |
Study Name: Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide Condition: Epilepsy, Partial Date: 2011-05-09 Interventions: Drug: Lacosamide 4-Week Titrat |
Completed |
Study Name: An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy Condition: Epilepsy, Partial Date: 2011-04-07 Interventions: Other: no intervention non-interventional study Othe |
Completed |
Study Name: Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy Condition: Partial Epilepsy Date: 2010-08-24 Interventions: Drug: Lacosamide |
Completed |
Study Name: Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy Condition: Partial Epilepsy Date: 2010-01-08 Interventions: Drug: VX-765 300mg Oral Tablet, 900mg TID |